selinexor
Selinexor is a drug used to treat Multiple Myeloma, Acute Myeloid Leukemia, Glioblastoma, and other conditions. Selinexor is being actively studied in 47 studies and prior, has been studied in 21.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Karyopharm Therapeutics Inc | Memorial Sloan Kettering Cancer Center | Bhavana Bhatnagar |
| H. Lee Moffitt Cancer Center and Research Institute | H. Lee Moffitt Cancer Center and Research Institute | Erin Bertino |
| St. Jude Children's Research Hospital | Dana Farber Cancer Institute | David E Gerber |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Soft Tissue Sarcoma
- +3 more
- Selinexor
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2022-04-07
Apr 7, 2022M
Withdrawn
- Solid Tumor Malignancy
- Selinexor
- Irinotecan
- Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
2021-12-14
Dec 14, 2021U
Completed
- Soft Tissue Sarcoma
- Selinexor
- Doxorubicin
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2021-11-26
Nov 26, 2021J
Recruiting
- Multiple Myeloma
- Selinexor
- +4 more
- Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
2022-03-03
Mar 3, 2022H
Not yet recruiting
- Extramedullary Multiple Myeloma
- Selinexor
- CT103A
- (no location specified)
2022-01-20
Jan 20, 2022G
Terminated
- Colorectal Neoplasm
- Selinexor
- +3 more
- Antwerpen, Belgium
- +1 more
2022-02-07
Feb 7, 2022W
N
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022H
Active, not recruiting
- Leukemia
- +2 more
- Selinexor
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021W
Recruiting
- Myeloma Multiple
- +2 more
- Selinexor
- +3 more
- Brooklyn, New York
- +1 more
2022-01-20
Jan 20, 2022U
Recruiting
- Primary Myelofibrosis
- +2 more
- Selinexor
- Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021H
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +2 more
- Tampa, Florida
- +1 more
2022-01-11
Jan 11, 2022G
Recruiting
- Sarcoma,Soft Tissue
- Selinexor
- Barcelona, Spain
- +5 more
2021-11-16
Nov 16, 2021H
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +4 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021K
Recruiting
- Metastatic Colorectal Cancer
- Selinexor
- +3 more
- Los Angeles, California
- +2 more
2022-02-24
Feb 24, 2022G
Completed
- Acute Myeloid Leukemia (Relapsed/Refractory)
- Selinexor
- +2 more
- Frankfurt am Main, Hessen, Germany
- +2 more
2021-08-01
Aug 1, 2021K
Recruiting
- Multiple Myeloma, Refractory
- Selinexor
- +2 more
- Patra, Achaia, Greece
- +15 more
2022-04-04
Apr 4, 2022N
Not yet recruiting
- Anaplastic Astrocytoma
- +4 more
- Radiation Therapy
- Selinexor
- (no location specified)
2022-03-11
Mar 11, 2022M
Recruiting
- Recurrent Histiocytic and Dendritic Cell Neoplasm
- +3 more
- Choline Salicylate
- Selinexor
- Rochester, MinnesotaMayo Clinic in Rochester
2022-04-04
Apr 4, 2022N
Completed
- Peripheral T-cell Lymphoma
- Selinexor
- ICE Chemotherapy
- Singapore, SingaporeNational Cancer Centre Singapore
2021-04-27
Apr 27, 2021T
Completed
- B-cell Lymphoma
- selinexor
- +6 more
- Bruxelles, Belgium
- +7 more
2021-12-06
Dec 6, 2021U
Recruiting
- Non-small Cell Lung Cancer
- Selinexor
- Docetaxel
- Aurora, Colorado
- +3 more
2022-03-22
Mar 22, 2022N
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
- Singapore, SingaporeNational University Hospital
2021-08-31
Aug 31, 2021S
Recruiting
- Acute Leukemia of Ambiguous Lineage in Relapse
- +3 more
- Venetoclax
- +6 more
- Memphis, TennesseeSt. Jude Children's Research Hospital
2021-11-18
Nov 18, 2021M
Completed
- Ovarian Cancer
- Endometrial Cancer
- Paclitaxel
- +2 more
- Middletown, New Jersey
- +2 more
2021-04-22
Apr 22, 2021